Skip to main content
Erschienen in: European Radiology 2/2019

02.08.2018 | Breast

Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient

verfasst von: Jin You Kim, Jin Joo Kim, Ji Won Lee, Nam Kyung Lee, Geewon Lee, Taewoo Kang, Heesung Park, Yo Han Son, Robert Grimm

Erschienen in: European Radiology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the value of the whole-lesion histogram apparent diffusion coefficient (ADC) metrics for differentiating low-risk from non-low-risk ductal carcinoma in situ (DCIS).

Methods

The authors identified 93 women with pure DCIS who had undergone preoperative MR imaging and diffusion-weighted imaging from 2013 to 2016. Histogram analysis of pixel-based ADC data of the whole tumour volume was performed by two radiologists using a software tool. The results were compared between low-risk and non-low-risk DCIS. Associations between quantitative ADC metrics and low-risk DCIS were evaluated by receiver operating characteristics (ROC) curve and logistic regression analyses.

Results

In whole-lesion histogram analysis, mean ADC and 5th, 50th and 95th percentiles of ADC were significantly different between low-risk and non-low-risk DCIS (1.522, 1.207, 1.536 and 1.854 × 10−3 mm2/s versus 1.270, 0.917, 1.261 and 1.657 × 10−3 mm2/s, respectively; p = .004, p = .003, p = .004 and p = .024, respectively). ROC curve analysis for differentiating low-risk DCIS revealed that 5th percentile ADC yielded the largest area under the curve (0.786) among the metrics of whole-lesion histogram, and the optimal cut-off point was 1.078 × 10−3 mm2/s (sensitivity 80%, specificity 75.9%, p = .001). Multivariate regression analysis revealed that a high 5th percentile of ADC (> 1.078× 10−3 mm2/s; odds ratio [OR] = 10.494, p = .016), small tumour size (≤ 2 cm; OR = 12.692, p = .008) and low Ki-67 status (< 14%; OR = 10.879, p = .046) were significantly associated with low-risk DCIS.

Conclusions

Assessment with whole-lesion histogram analysis of the ADC could be helpful for identifying patients with low-risk DCIS.

Key Points

• Whole-lesion histogram ADC metrics could be helpful for differentiating low-risk from non-low-risk DCIS.
• A high 5th percentile ADC was a significant factor associated with low-risk DCIS.
• Risk stratification of DCIS is important for their management.
Literatur
1.
Zurück zum Zitat Lippman M (2002) Why study ductal carcinoma in situ. In: Silverstein MJ, Recht A, Lagios MD (eds) Ductal carcinoma in situ of the breast, 2nd edn. Lippincott William and Wilkins, Philadelphia, pp 12–16 Lippman M (2002) Why study ductal carcinoma in situ. In: Silverstein MJ, Recht A, Lagios MD (eds) Ductal carcinoma in situ of the breast, 2nd edn. Lippincott William and Wilkins, Philadelphia, pp 12–16
2.
Zurück zum Zitat Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103:2481–2484CrossRef Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103:2481–2484CrossRef
3.
Zurück zum Zitat Page DL, Dupont WD, Rogers LW, Landenberger M (1982) Intraductal carcinoma of the breast: Follow-up after biopsy only. Cancer 49:751–758CrossRef Page DL, Dupont WD, Rogers LW, Landenberger M (1982) Intraductal carcinoma of the breast: Follow-up after biopsy only. Cancer 49:751–758CrossRef
4.
Zurück zum Zitat Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76:1197–1200CrossRef Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76:1197–1200CrossRef
5.
Zurück zum Zitat Sagara Y, Mallory MA, Wong S et al (2015) Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA surg 150:739–745CrossRef Sagara Y, Mallory MA, Wong S et al (2015) Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA surg 150:739–745CrossRef
6.
Zurück zum Zitat Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C (2007) Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 17:2646–2655CrossRef Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C (2007) Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 17:2646–2655CrossRef
7.
Zurück zum Zitat Guo Y, Cai Y, Cai Z et al (2002) Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 16:172–178CrossRef Guo Y, Cai Y, Cai Z et al (2002) Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 16:172–178CrossRef
8.
Zurück zum Zitat Iima M, Le Bihan D, Okumura R et al (2011) Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study. Radiology 260:364–372CrossRef Iima M, Le Bihan D, Okumura R et al (2011) Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study. Radiology 260:364–372CrossRef
9.
Zurück zum Zitat Rahbar H, Partridge SC, Eby PR et al (2011) Characterisation of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol 21:2011–2019CrossRef Rahbar H, Partridge SC, Eby PR et al (2011) Characterisation of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol 21:2011–2019CrossRef
10.
Zurück zum Zitat Rahbar H, Partridge SC, DeMartini WB et al (2012) In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters. Radiology 263:374–382CrossRef Rahbar H, Partridge SC, DeMartini WB et al (2012) In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters. Radiology 263:374–382CrossRef
11.
Zurück zum Zitat Rahbar H, Parsian S, Lam DL et al (2016) Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ? Clin Imaging 40:125–129CrossRef Rahbar H, Parsian S, Lam DL et al (2016) Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ? Clin Imaging 40:125–129CrossRef
12.
Zurück zum Zitat Hussein H, Chung C, Moshonov H, Miller N, Kulkarni SR, Scaranelo AM (2015) Evaluation of apparent diffusion coefficient to predict grade, microinvasion, and invasion in ductal carcinoma in situ of the breast. Acad Radiol 22:1483–1488CrossRef Hussein H, Chung C, Moshonov H, Miller N, Kulkarni SR, Scaranelo AM (2015) Evaluation of apparent diffusion coefficient to predict grade, microinvasion, and invasion in ductal carcinoma in situ of the breast. Acad Radiol 22:1483–1488CrossRef
13.
Zurück zum Zitat Just N (2014) Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer 111:2205–2213CrossRef Just N (2014) Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer 111:2205–2213CrossRef
14.
Zurück zum Zitat Silverstein MJ, Poller DN, Waisman JR et al (1995) Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154–1157CrossRef Silverstein MJ, Poller DN, Waisman JR et al (1995) Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154–1157CrossRef
15.
Zurück zum Zitat Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155–168 Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155–168
16.
Zurück zum Zitat Moeder CB, Giltnane JM, Harigopal M et al (2007) Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray–based assessment of outcome. J Clin Oncol 25:5418–5425CrossRef Moeder CB, Giltnane JM, Harigopal M et al (2007) Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray–based assessment of outcome. J Clin Oncol 25:5418–5425CrossRef
17.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef
18.
Zurück zum Zitat Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102:170–178CrossRef Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102:170–178CrossRef
19.
Zurück zum Zitat Ernster VL, Ballard-Barbash R, Barlow WE et al (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546–1554CrossRef Ernster VL, Ballard-Barbash R, Barlow WE et al (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546–1554CrossRef
20.
Zurück zum Zitat Bickel H, Pinker K, Polanec S et al (2017) Diffusion-weighted imaging of breast lesions: region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values. Eur Radiol 27:1883–1892CrossRef Bickel H, Pinker K, Polanec S et al (2017) Diffusion-weighted imaging of breast lesions: region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values. Eur Radiol 27:1883–1892CrossRef
21.
Zurück zum Zitat Partridge SC, Mullins CD, Kurland BF et al (2010) Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 194:1664–1673CrossRef Partridge SC, Mullins CD, Kurland BF et al (2010) Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 194:1664–1673CrossRef
22.
Zurück zum Zitat Kul S, Eyuboglu I, Cansu A, Alhan E (2014) Diagnostic efficacy of the diffusion weighted imaging in the characterisation of different types of breast lesions. J Magn Reson Imaging 40:1158–1164CrossRef Kul S, Eyuboglu I, Cansu A, Alhan E (2014) Diagnostic efficacy of the diffusion weighted imaging in the characterisation of different types of breast lesions. J Magn Reson Imaging 40:1158–1164CrossRef
23.
Zurück zum Zitat Rosenkrantz AB (2013) Histogram-based apparent diffusion coefficient analysis: an emerging tool for cervical cancer characterisation? AJR Am J Roentgenol 200:311–313CrossRef Rosenkrantz AB (2013) Histogram-based apparent diffusion coefficient analysis: an emerging tool for cervical cancer characterisation? AJR Am J Roentgenol 200:311–313CrossRef
24.
Zurück zum Zitat Kim EJ, Kim SH, Park GE et al (2015) Histogram analysis of apparent diffusion coefficient at 3.0 T: correlation with prognostic factors and subtypes of invasive ductal carcinoma. J Magn Reson Imaging 42:1666–1678CrossRef Kim EJ, Kim SH, Park GE et al (2015) Histogram analysis of apparent diffusion coefficient at 3.0 T: correlation with prognostic factors and subtypes of invasive ductal carcinoma. J Magn Reson Imaging 42:1666–1678CrossRef
25.
Zurück zum Zitat Mori N, Ota H, Mugikura S et al (2015) Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology 274:66–73CrossRef Mori N, Ota H, Mugikura S et al (2015) Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology 274:66–73CrossRef
26.
Zurück zum Zitat Choi Y, Kim SH, Youn IK et al (2017) Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype. PLoS One 12:e0177903CrossRef Choi Y, Kim SH, Youn IK et al (2017) Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype. PLoS One 12:e0177903CrossRef
27.
Zurück zum Zitat Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS (2007) Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 245:684–691CrossRef Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS (2007) Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 245:684–691CrossRef
28.
Zurück zum Zitat Kwee RM, Dik AK, Sosef MN et al (2014) Interobserver reproducibility of diffusion-weighted MRI in monitoring tumor response to neoadjuvant therapy in esophageal cancer. PLoS One 9:e92211CrossRef Kwee RM, Dik AK, Sosef MN et al (2014) Interobserver reproducibility of diffusion-weighted MRI in monitoring tumor response to neoadjuvant therapy in esophageal cancer. PLoS One 9:e92211CrossRef
29.
Zurück zum Zitat Suo S, Zhang K, Cao M et al (2016) Characterisation of breast masses as benign or malignant at 3.0 T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient. J Magn Reson Imaging 43:894–902CrossRef Suo S, Zhang K, Cao M et al (2016) Characterisation of breast masses as benign or malignant at 3.0 T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient. J Magn Reson Imaging 43:894–902CrossRef
30.
Zurück zum Zitat Hirano M, Satake H, Ishigaki S, Ikeda M, Kawai H, Naganawa S (2012) Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters. AJR Am J Roentgenol 198:717–722CrossRef Hirano M, Satake H, Ishigaki S, Ikeda M, Kawai H, Naganawa S (2012) Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters. AJR Am J Roentgenol 198:717–722CrossRef
31.
Zurück zum Zitat Matsumoto Y, Kuroda M, Matsuya R et al (2009) In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology. Oncol Rep 22:641–648 Matsumoto Y, Kuroda M, Matsuya R et al (2009) In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology. Oncol Rep 22:641–648
32.
Zurück zum Zitat Kuerer HM (2011) Rational individualised selection of adjuvant therapy for ductal carcinoma in situ. Lancet Oncol 12:2–3CrossRef Kuerer HM (2011) Rational individualised selection of adjuvant therapy for ductal carcinoma in situ. Lancet Oncol 12:2–3CrossRef
33.
Zurück zum Zitat Rutter CE, Park HS, Killelea BK, Evans SB (2015) Growing use of mastectomy for ductal carcinoma-in situ of the breast among young women in the United States. Ann Surg Oncol 22:2378–2386CrossRef Rutter CE, Park HS, Killelea BK, Evans SB (2015) Growing use of mastectomy for ductal carcinoma-in situ of the breast among young women in the United States. Ann Surg Oncol 22:2378–2386CrossRef
34.
Zurück zum Zitat Kim J, Son EJ, Youk JH et al (2011) MRI findings of pure ductal carcinoma in situ: kinetic characteristics compared according to lesion type and histopathologic factors. AJR Am J Roentgenol 196:1450–1456CrossRef Kim J, Son EJ, Youk JH et al (2011) MRI findings of pure ductal carcinoma in situ: kinetic characteristics compared according to lesion type and histopathologic factors. AJR Am J Roentgenol 196:1450–1456CrossRef
35.
Metadaten
Titel
Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient
verfasst von
Jin You Kim
Jin Joo Kim
Ji Won Lee
Nam Kyung Lee
Geewon Lee
Taewoo Kang
Heesung Park
Yo Han Son
Robert Grimm
Publikationsdatum
02.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5666-x

Weitere Artikel der Ausgabe 2/2019

European Radiology 2/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.